Most importantly, we demonstrated the successful use of a Gli inhibitor in vivo to suppress the growth of lung adenocarcinoma in a xenograft model without any toxicity and in these tumors showed histologically that Gli inhibition led to decreased Gli expression, increased E-Cadherin, and decreased markers of cellular proliferation. Here, GLI1 is linked to lung adenocarcinoma.